M Verstraete, D Collen. Show Affiliations »
Abstract
Mesh: See more » AcylationAmino Acid SequenceAnimalsAntifibrinolytic AgentsEnzyme ActivationFibrin Fibrinogen Degradation Products/metabolismFibrinolysin/metabolismFibrinolysisFibrinolytic Agents/adverse effectsFibrinolytic Agents/therapeutic useHemorrhage/chemically inducedHomeostasisHumansMyocardial Infarction/drug therapyPlasminogen/metabolismPlasminogen Activators/metabolismProtein ConformationPulmonary Embolism/drug therapyRabbitsRecombinant Proteins/therapeutic useStreptokinase/metabolismStreptokinase/therapeutic useTissue Plasminogen Activator/metabolismUrokinase-Type Plasminogen Activator/metabolismUrokinase-Type Plasminogen Activator/therapeutic usealpha-2-Antiplasmin/metabolism
Substances: See more » Antifibrinolytic AgentsFibrin Fibrinogen Degradation ProductsFibrinolytic AgentsRecombinant Proteinsalpha-2-Antiplasminplasmin-plasmin inhibitor complexPlasminogenStreptokinasePlasminogen ActivatorsTissue Plasminogen ActivatorFibrinolysinUrokinase-Type Plasminogen Activator
Year: 1986 PMID: 2423156
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113